Quantum Genomics Societe Anonyme stock analysis
Quantum Genomics Societe Anonyme (ALQGC) Stock Price & Analysis
ALQGC Stock Chart & Stats
- Day’s Range
- EUR 0.07 - EUR 0.07
- 52-Week Range
- EUR 0.03 - EUR 0.08
- Previous Close
- EUR 0.07
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 5.01M
- Enterprise Value
- EUR 7.34T
- Total Cash (Recent Filing)
- EUR 301.02K
- Total Debt (Recent Filing)
- EUR 2.64M
- Price to Earnings (P/E)
- ―
- Beta
- -0.00
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
ALQGC FAQ
What was Quantum Genomics Societe Anonyme’s price range in the past 12 months?
What is Quantum Genomics Societe Anonyme’s market cap?
When is Quantum Genomics Societe Anonyme’s upcoming earnings report date?
How were Quantum Genomics Societe Anonyme’s earnings last quarter?
Is Quantum Genomics Societe Anonyme overvalued?
Does Quantum Genomics Societe Anonyme pay dividends?
What is Quantum Genomics Societe Anonyme’s EPS estimate?
How many shares outstanding does Quantum Genomics Societe Anonyme have?
What happened to Quantum Genomics Societe Anonyme’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Quantum Genomics Societe Anonyme?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Quantum Genomics Societe Anonyme
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mathieu Bigois
- Employees
- 3
- Website
- www.quantum-genomics.com
- Address
- 33 rue Marbeuf, Paris, 75008, FR
Quantum Genomics Societe Anonyme (ALQGC) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 3 | 9 |
| Technical Analysis | 4 | 1 | 1 |
| Moving Averages | 2 | 2 | 8 |

